Clene Nanomedicine – Neurodegenerative Diseases
Rob Etherington, CEO at Clene Nanomedicine discusses the company's lead drug candidate CNM-Au8, a catalytically active gold nanotherapeutic that drives ...
819 articles
Rob Etherington, CEO at Clene Nanomedicine discusses the company's lead drug candidate CNM-Au8, a catalytically active gold nanotherapeutic that drives ...
Vivek Subbiah, MD, Associate Professor in the Investigational Cancer Therapeutics department and Center Clinical Medical Director of the Clinical Center...
Ben Chew discuss two abstracts made available virtually by the World Congress of Endourology (WCET) titled " Identifying Predictors of Sepsis Post-Urete...
Jeffrey Stark, MD, Head of US Medical Immunology at UCB discusses new data from a network meta-analysis (NMA) demonstrating that bimekizumab was associa...
Screening and earlier detection are key in the fight against cancer. Learn more on Health Professional Radio.
Michael Ackerman, MD, PhD, Windland Smith Rice Cardiovascular Genomics Research Professor and Professor of Medicine, Pediatrics, and Pharmacology at The...
Susan Manzi, Professor of Medicine and Chair of the Medicine Institute at Allegheny Health Network discusses new analyses presented at the 2021 American...
MeiLan Han, MD MS, pulmonologist at the University of Michigan and author of the book "Breathing Lessons: a Doctor’s Guide to Lung Health" discusses t...
Jorge Gomez, MD, Medical Director, Thoracic Oncology Program and World Trade Center oncology clinic, Mount Sinai is here on behalf of Pfizer and the Ame...
Corey Lawson, Vice President of Product Strategy at Accuray, a company that develops unique market-changing radiotherapy solutions, discusses the fast c...